Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of CDCA and Colesevelam on GLP-1 After RYGB
NCT02876484Phase 4Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chenodeoxycholic acid, colesevelam in obesity, sponsored by Copenhagen University Hospital - Hvidovre. Started Jun 2016; status: completed.
02
Drugs
chenodeoxycholic acidcolesevelam
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02876484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02876484.